ImmunoSigns is a biotechnology company. It offers services in project management and R&D activities within biotechnology and immunodetection. The company focuses on the development and production of polyclonal and monoclonal antibodies and design and production of immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.